SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
This Quarter Return
+4.22%
1 Year Return
+41.48%
3 Year Return
+28.47%
5 Year Return
+53.25%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$10.8B
(+5.2%)
Cap. Flow
+$38.4M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
22.74%
Holding
356
New
34
Increased
105
Reduced
150
Closed
20
Top Buys
| 1 |
Pfizer
PFE
|
$124M |
| 2 |
JPMorgan Chase
JPM
|
$65.9M |
| 3 |
REXMY
REXAM PLC ADR - NEW
REXMY
|
$45.1M |
| 4 |
CEO
CNOOC Limited
CEO
|
$16.6M |
| 5 |
GSK
GSK
|
$14.4M |
Top Sells
| 1 |
Dominion Energy
D
|
$137M |
| 2 |
AstraZeneca
AZN
|
$103M |
| 3 |
ABB
ABB Ltd.
ABB
|
$12.3M |
| 4 |
ConocoPhillips
COP
|
$8.4M |
| 5 |
Johnson & Johnson
JNJ
|
$7.67M |
Sector Composition
| 1 | Healthcare | 14.3% |
| 2 | Energy | 10.99% |
| 3 | Consumer Staples | 9.11% |
| 4 | Technology | 8.91% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
1
DELISTED
Unilever NV New York Registry Shares
UN
| $309M | 2.84% | 7,050,734 +32,737 | +0.5% | +$1.43M |
|
|
RDS.B
2
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $293M | 2.7% | 3,366,047 +17,298 | +0.5% | +$1.51M |
|
|
3
ConocoPhillips
COP
$124B
| $251M | 2.32% | 2,931,477 -97,994 | -3% | -$8.4M |
|
4
HSBC
HSBC
$224B
| $243M | 2.24% | 4,779,758 +129,686 | +3% | +$6.59M |
|
|
5
Johnson & Johnson
JNJ
$427B
| $241M | 2.22% | 2,301,046 -73,284 | -3% | -$7.67M |
|
6
Merck
MRK
$210B
| $240M | 2.21% | 4,141,002 -125,078 | -3% | -$7.24M |
|
7
Intel
INTC
$107B
| $227M | 2.09% | 7,336,146 -240,497 | -3% | -$7.43M |
|
8
BCE
BCE
$23.3B
| $225M | 2.08% | 4,964,263 -54,303 | -1% | -$2.46M |
|
9
Microsoft
MSFT
$3.77T
| $223M | 2.06% | 5,347,191 -132,545 | -2% | -$5.53M |
|
10
NextEra Energy, Inc.
NEE
$148B
| $216M | 1.99% | 2,105,866 -67,187 | -3% | -$6.89M |
|
11
Altria Group
MO
$113B
| $208M | 1.92% | 4,956,081 -151,778 | -3% | -$6.37M |
|
12
Eli Lilly
LLY
$657B
| $207M | 1.91% | 3,332,654 -112,454 | -3% | -$6.99M |
|
13
Chevron
CVX
$324B
| $205M | 1.89% | 1,570,763 -3,238 | -0.2% | -$423K |
|
|
14
JPMorgan Chase
JPM
$829B
| $204M | 1.88% | 3,538,010 +1,143,418 | +48% | +$65.9M |
|
15
Cisco
CSCO
$274B
| $201M | 1.85% | 8,069,858 -189,990 | -2% | -$4.72M |
|
16
GE Aerospace
GE
$292B
| $195M | 1.8% | 7,415,061 -115,883 | -2% | -$3.05M |
|
|
RTN
17
DELISTED
Raytheon Company
RTN
| $186M | 1.71% | 2,013,705 -50,943 | -2% | -$4.7M |
|
|
DD
18
DELISTED
Du Pont De Nemours E I
DD
| $186M | 1.71% | 2,835,161 -32,257 | -1% | -$2.11M |
|
19
3M
MMM
$82.8B
| $185M | 1.7% | 1,289,499 -48,650 | -4% | -$6.97M |
|
20
AT&T
T
$209B
| $180M | 1.66% | 5,098,124 +40,091 | +0.8% | +$1.42M |
|
|
21
AstraZeneca
AZN
$248B
| $178M | 1.64% | 2,393,638 -1,392,175 | -37% | -$103M |
|
22
Philip Morris
PM
$260B
| $173M | 1.6% | 2,055,891 -24,931 | -1% | -$2.1M |
|
23
MetLife
MET
$54.1B
| $171M | 1.57% | 3,072,394 -9,818 | -0.3% | -$545K |
|
24
Vodafone
VOD
$28.8B
| $170M | 1.57% | 5,083,604 +107,040 | +2% | +$3.57M |
|
25
Travelers Companies
TRV
$61.1B
| $167M | 1.54% | 1,779,547 -50,443 | -3% | -$4.75M |
|